NCI N01-CM-67895-01/CM/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.

Chachoua A, Oratz R, Liebes L, Alter RS, Felice A, Peace D, Vilcek J, Blum RH. Chachoua A, et al. J Immunother Emphasis Tumor Immunol. 1994 Aug;16(2):132-41. doi: 10.1097/00002371-199408000-00007. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7804528 Clinical Trial.

Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor.

Chachoua A, Oratz R, Hoogmoed R, Caron D, Peace D, Liebes L, Blum RH, Vilcek J. Chachoua A, et al. J Immunother Emphasis Tumor Immunol. 1994 Apr;15(3):217-24. doi: 10.1097/00002371-199404000-00008. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8032545 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters